Table 2.
Mothers by initial diagnosis, and their progression (n=229), group II: mothers enrolled >1 year after birth of a neonatal lupus (NL)-affected child (n=126)
| Initial diagnosis at enrolment |
n1* | n2† | Diagnosis after follow-up |
n | Mean time to diagnosis |
Mean follow-up (years) |
CHB‡ | Rash§ | Time from birth to latest follow-up |
|---|---|---|---|---|---|---|---|---|---|
| Asymptomatic | 29 | 19 | Asymptomatic | 11 | – | 4.9 | 10 | 1 | 9 |
| Pauci-UAS | 1 | 1 | 1.5 | 1 | 0 | 3.2 | |||
| Probable SS | 2 | 4 | 8.1 | 2 | 0 | 11 | |||
| Definite SS | 2 | 3 | 7.5 | 2 | 0 | 10 | |||
| SLE | 2 | 8 | 10.6 | 2 | 0 | 12 | |||
| SLE/SS | 1 | 5 | 10.5 | 1 | 0 | 14 | |||
| Pauci-UAS | 23 | 17 | Pauci-UAS | 10 | – | 4.5 | 8 | 2 | 9 |
| Poly-UAS | 3 | 1 | 4.5 | 3 | 0 | 7 | |||
| Probable SS | 1 | 4 | 5.7 | 1 | 0 | 20.2 | |||
| SLE | 2 | 6 | 9.7 | 2 | 0 | 12 | |||
| SLE/SS | 1 | 2 | 3.8 | 1 | 0 | 10.9 | |||
| Poly-UAS | 12 | 7 | Poly-UAS | 4 | – | 3.6 | 3 | 1 | 13 |
| Probable SS | 1 | 3 | 8.3 | 0 | 1 | 10.2 | |||
| SLE/SS | 2 | 3 | 10.2 | 2 | 0 | 12 | |||
| Probable SS | 35 | 21 | Probable SS | 16 | – | 5.5 | 11 | 5 | 13 |
| Definite SS | 1 | 2 | 7 | 1 | 0 | 12 | |||
| SLE/SS | 4 | 3 | 4.5 | 2 | 2 | 9 | |||
| Definite SS | 13 | 13 | Definite SS | 11 | – | 4.7 | 9 | 2 | 15 |
| SLE/SS | 2 | 7 | 8.1 | 2 | 0 | 12 | |||
| SLE | 32 | 22 | SLE | 22 | – | 6.2 | 16 | 6 | 13 |
| SLE/SS | 39 | 27 | SLE/SS | – | 4.4 | 21 | 6 | 15 |
The maternal mean age at the birth of the NL child was 30 years in both groups (16–44 years). The ethnic distribution was: 74.1% Caucasian, 9.7% African–American, 8.4% Hispanic, 5.0% Asian and 2.8% unknown/unanswered. Of 229 mothers studied, 171 had at least 1 NL child with CHB and 58 only had an NL rash child.
n1, Total number of mothers who enrolled with specific diagnoses
n2, mothers who were followed for at least 6 months
CHB, mothers who had a child with congenital heart block (CHB), or a child with CHB+rash
rash, mothers who had a child with NL rash only. SLE, systemic lupus erythematosus
SS, Sjögren syndrome
UAS, undifferentiated autoimmune syndrome. Extended rep